Thank you for the question.
This is definitely important. We can't expect all people to be able to come to health care facilities, so a large part of our work involves going into communities and diagnosing in communities. The thing about drug-resistant TB, though, is that it's a diagnosis that has to take place inside a higher-level lab. It's great that we continue to go into communities, but there has to be a transmission of the specimens. As it stands now, we collect specimens, but they still have to be transported to a higher-level lab.
We do need a better diagnostic test that can make the diagnosis in the community. Again, that has to be followed up with a much more tolerable regimen. As it stands now, we don't have a tolerable regimen—tolerable to patients and easy to prescribe by practitioners—and I think that's one of the reasons why diagnosis is still weak when it comes to drug-resistant TB. We need a better treatment.